Do’s and Don’ts” for intraarterial chemotherapy for retinoblastoma- What ophthalmologist and interventional radiologist need to know?
Intra-arterial chemotherapy (IAC) has emerged as the primary treatment option for retinoblastoma management. It enables the localized delivery of a higher concentration of chemotherapeutic agents (melphalan, carboplatin and topotecan) in the ophthalmic artery, enhancing tumour control and potentiall...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Medknow Publications
2025-06-01
|
| Seri Bilgileri: | Indian Journal of Ophthalmology |
| Konular: | |
| Online Erişim: | https://journals.lww.com/10.4103/IJO.IJO_2912_24 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
